2008 Annual Meeting

Session: Modeling in the Pharmaceutical Industry I

The development of pharmaceuticals involves the development of both process and chemistry/formulation to produce the active pharmaceutical ingredient/final drug product. We invite contributions from industry and academia that address system-level process simulation (cycle time analysis, mass and energy balances, equipment usage, scheduling etc.) and/or more detailed unit operations modeling during process development and scale-up in pharmaceutical synthesis and formulation (e.g. reaction steps, kinetics, solvent chasing, crystallization, filtration, drying). Particular consideration will be given to examples of model development from laboratory data with model validation during scale-up and clear savings or greater process understanding as a result of process modeling.

Chair

Richard Schild, Bristol-Myers Squibb

Co-Chair

Christopher Burcham, Eli Lilly and Company

Presentations

08:30 AM

08:50 AM

David Willcox, Deepak Ahuja, Tim Towne, Wenke Li, Todd McDermott

09:10 AM

Daniel Hallow, Justin Burt, Boguslaw Mudryk, Lucius Rossano, Srinivas Tummala

09:30 AM

Pavan Kumar Akkisetty, Pradeep Suresh, Gintaras Reklaitis, Venkat Venkatasubramanian

10:00 AM

Fesia L. Laksmana, Paul J.A. Hartman Kok, Herman Vromans, Henderik W. Frijlink, Kees Van der Voort Maarschalk

10:20 AM

Venkat Koganti, Sumit Luthra, Evgenyi Shalaev, Larry Gatlin

10:40 AM